Dynamic O-GlcNAcylation and irreversible advanced glycation end-product modifications of cardiomyocyte proteins drive the functional and structural abnormalities characteristic of diabetic cardiomyopathy.
Enzymatic and non-enzymatic post-translational modifications linking diabetes and heart disease. © 2014 The Authors. Journal of Diabetes Investigation published by Asian Association of the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd.
山本 et al. (Thu,) conducted a editorial in Diabetic cardiomyopathy. Dynamic O-GlcNAcylation and irreversible advanced glycation end-product modifications of cardiomyocyte proteins drive the functional and structural abnormalities characteristic of diabetic cardiomyopathy.